Pelorus Venture Capital
Pelorus Venture Capital specializes in providing funding for seed and early stage companies. With a focus on supporting the growth and development of emerging businesses, Pelorus Venture Capital plays a crucial role in helping entrepreneurs bring their innovative ideas to market. Through strategic investments and guidance, Pelorus Venture Capital aims to fuel the success of startups and contribute to the expansion of the entrepreneurial ecosystem.
Past deals in Newfoundland
Sequence Bio
Pre Seed Round in 2015
Sequence Bio is a biotechnology company focused on advancing drug discovery and development through genome therapy. Leveraging the unique genetic characteristics of isolated populations, particularly those in Newfoundland, the company collects DNA and health information to enhance the identification of drug targets. This approach aims to improve the treatment of complex and inherited diseases, ultimately addressing the high failure rate of drug candidates and expediting access to effective therapies for patients in need. By utilizing genetic insights, Sequence Bio seeks to transform the landscape of medicine and deliver better health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.